Back to Search
Start Over
Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42).
- Source :
-
Vaccine [Vaccine] 2010 Jun 17; Vol. 28 (28), pp. 4515-22. Date of Electronic Publication: 2010 May 15. - Publication Year :
- 2010
-
Abstract
- The complement fragment C3d mediates B-cell activation via simultaneous engagement of the B-cell receptor and CD21 by antigen/C3d conjugates. Several studies demonstrated the potential of C3d as a molecular adjuvant for vaccination. In this work, C3d exerted differential effects on humoral immune responses after gene gun immunization of mice with plasmids encoding the malaria blood stage antigen MSP1(42) depending on the nature of the protein (Plasmodium falciparum vs. Plasmodium berghei MSP), the localization of the C3d moiety (C-terminal vs. N-terminal), and the presence of putative N-glycosylation sites. No improvement of protective efficacy by C3d attachment or mutation of glycosylation sites could be demonstrated by in vitro parasite growth inhibition assays or in vivo blood stage parasite challenges. Our data underscore the controversial role of C3d as molecular adjuvant.<br /> (2010 Elsevier Ltd. All rights reserved.)
- Subjects :
- Adjuvants, Immunologic pharmacology
Animals
Antibodies, Protozoan blood
Antibody Formation
Female
Glycosylation
Immunization methods
Immunoglobulin G blood
Interferon-gamma immunology
Interleukin-4 immunology
Malaria immunology
Merozoite Surface Protein 1 genetics
Mice
Mice, Inbred BALB C
Mutation
Recombinant Proteins immunology
Vaccines, DNA immunology
Complement C3d immunology
Malaria prevention & control
Malaria Vaccines immunology
Merozoite Surface Protein 1 immunology
Plasmodium berghei immunology
Plasmodium falciparum immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2518
- Volume :
- 28
- Issue :
- 28
- Database :
- MEDLINE
- Journal :
- Vaccine
- Publication Type :
- Academic Journal
- Accession number :
- 20438877
- Full Text :
- https://doi.org/10.1016/j.vaccine.2010.04.054